Loading...
Masimo reported consolidated revenue of $565.3 million, representing 85.3% growth compared to Q2 2021. Healthcare revenue was $357.0 million, a 17.0% increase, and non-healthcare revenue was $208.3 million. GAAP net income was $18.1 million, or $0.33 per diluted share, while non-GAAP net income was $74.8 million, or $1.35 per diluted share.
Consolidated revenue was $565 million.
Healthcare revenue was $357 million, representing 17% reported growth and 19% constant currency growth.
Non-healthcare revenue was $208 million.
Repurchased 3 million shares of Masimo common stock for $401 million.
The Company provided the following estimates for its third-quarter and full-year 2022 guidance: